Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu

Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.


Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Publications & Presentations

<< 5 6 7 8 9 10 11 > >>
    36. Medina M, Schwier N C, Miller J L, Miller M M, Skrepnek G H. Career Skills Assessment in a Doctor of Pharmacy Curriculum. American journal of pharmaceutical education. 2018; 82 : 6300

    37. Keast S, Holderread B, Cothran T, Skrepnek G H. Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost. Journal of the American Pharmacists Association : JAPhA. 2018; 58 : 485-491

    38. Gentry C A, Giancola S, Kurdgelashvili G, Thind S, Skrepnek G H, Williams R J. A Propensity-Matched Analysis Between Standard Versus Tapered Oral Vancomycin Courses for the Management of Recurrent Clostridium difficile Infection. IDSA: Open Forum Infect Dis. 2017; 4 : 1-6

    39. Skrepnek G H. Health Economics and Outcomes Research in Cancer. Springer. 2017

    40. Miller J L, Lepa T M, Ranallo C, Chaaban H, Skrepnek G H, Johnson P N. Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended?. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2017; 18 : e615-e620

<< 5 6 7 8 9 10 11 > >>



Grants

<< 1 2 3 4 >>
    6. C1097002 - Improving evidence-based antibiotic use for treatment of infections commonly seen in long term . Federal Non-NIH. Start Date: 2019. End Date: 2020.

    7. C2010628 - Drug Utilization Review 2020 [Service Award]. State Agency. Start Date: 2019. End Date: 2020.

    8. C2015602 - 1815 Medication Therapy Management, Tele-MTM. Non-federal. Start Date: 2019. End Date: 2020.

    9. C7069901 - MTM Drug Utilization Review. Non-federal. Start Date: 2019. End Date: 2020.

    10. C7070101 - Study of Oklahoma Medicaid Assessing Outcomes Associated with Long-Acting Injectable Antipsychotics. Non-federal. Start Date: 2019. End Date: 2020.

<< 1 2 3 4 >>



Awards and Honors


no results

Education


no results

Administrative Assignments

                                                
     1. Role: Director. Scope: Department. Date: 2019.
                                                
     2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.